Amano Toshiyasu
Department of Urology, Nagano Red Cross Hospital, Japan.
Clin Calcium. 2013 Aug;23(8):1179-84.
Late-onset hypogonadism (LOH) is defined as the condition caused by the decline of testosterone by aging, along with various symptoms, including physical, psychological and sexual disturbance. Thus the principle of treatment for LOH is Androgen replacement therapy (ART) , and ART has been applied primarily in order to alleviate the various symptoms in LOH patients. The indication of ART for LOH is determined based on LOH symptoms assessed by aging males' symptoms (AMS) score and serum free testosterone levels. In abroad, several routes are available for the administration of testosterone, such as injection, patch, oral administration, etc. In Japan, intramuscular injection of testosterone enanthate every 2 to 4 weeks is widely indicated for treatment of LOH. It has also reported that ART using testosterone ointment once or twice a day appeared to improve those LOH symptoms. ART is a significant and safe procedure for anti-aging in male.
迟发性性腺功能减退(LOH)被定义为由衰老导致睾酮水平下降所引起的病症,伴有包括身体、心理和性方面紊乱在内的各种症状。因此,LOH的治疗原则是雄激素替代疗法(ART),并且ART主要是为了缓解LOH患者的各种症状而应用。基于通过老年男性症状(AMS)评分和血清游离睾酮水平评估的LOH症状来确定LOH的ART适应证。在国外,睾酮有几种给药途径,如注射、贴片、口服等。在日本,每2至4周肌肉注射庚酸睾酮被广泛用于LOH的治疗。也有报道称,每天使用一次或两次睾酮软膏的ART似乎可改善那些LOH症状。ART是男性抗衰的一种重要且安全的方法。